Literature DB >> 25763510

Extreme Contrast of Postprandial Remnant-Like Particles Formed in Abetalipoproteinemia and Homozygous Familial Hypobetalipoproteinemia.

Masa-Aki Kawashiri1, Hayato Tada, Marowa Hashimoto, Matsuo Taniyama, Takamitsu Nakano, Katsuyuki Nakajima, Takeshi Inoue, Mika Mori, Chiaki Nakanishi, Tetsuo Konno, Kenshi Hayashi, Atsushi Nohara, Akihiro Inazu, Junji Koizumi, Hirotaka Ishihara, Junji Kobayashi, Tsutomu Hirano, Hiroshi Mabuchi, Masakazu Yamagishi.   

Abstract

BACKGROUND: Familial hypobetalipoproteinemia (FHBL) and abetalipoproteinemia (ABL) are rare inherited forms of hypolipidemia. Their differential diagnosis is important for predicting of the prognosis and selecting appropriate therapy.
MATERIALS AND METHODS: Genetic analysis was performed in two patients with primary hypocholesterolemia born from consanguineous parents. The oral fat tolerance test (OFTT) was performed in one patient with FHBL (apoB-87.77) and one with ABL as well as in four normal control subjects. After overnight fasting, blood samples were drawn. Serum lipoprotein and remnant-like particle (RLP) fractions were determined by HPLC analysis.
RESULTS: Both patients with homozygous FHBL were asymptomatic probably because of preserved levels of fat-soluble vitamins, especially vitamin E. The patients with FHBL were homozygous because of novel apoB-83.52 and apoB-87.77 mutations, and although one of them (apoB-87.77) had fatty liver disease, microscopic findings suggesting nonalcoholic steatohepatitis were absent. Fasting apoB-48 and RLP-triglyceride levels in the patient with homozygous FHBL, which were similar to those in normal control subjects, increased after OFTT both in normal control subjects and the patient with FHBL but not in the patient with ABL, suggesting that the fat load administered was absorbed only in the patient with FHBL.
CONCLUSION: Although lipid levels in the patients with homozygous FHBL and ABL were comparable, fasting, postoral fat loading of apoB-48, as well as RLP-triglyceride levels, may help in the differential diagnosis of FHBL and ABL and provide a prompt diagnosis using genetic analysis in the future.

Entities:  

Year:  2015        PMID: 25763510      PMCID: PMC4486280          DOI: 10.1007/8904_2015_415

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  23 in total

1.  A 54-year-old diabetic man with low serum cholesterol.

Authors:  Ugur Turk; Gunes Basol; Burcu Barutcuoglu; Fahri Sahin; Sara Habif; Patrizia Tarugi; Oya Bayindir
Journal:  Clin Chem       Date:  2012-05       Impact factor: 8.327

2.  Post-prandial remnant lipoprotein metabolism in autosomal recessive hypercholesterolaemia.

Authors:  Hayato Tada; Masa-Aki Kawashiri; Akira Tanaka; Takamitsu Nakano; Katsuyuki Nakajima; Takeshi Inoue; Tohru Noguchi; Chiaki Nakanishi; Tetsuo Konno; Kenshi Hayashi; Atsushi Nohara; Akihiro Inazu; Junji Kobayashi; Hiroshi Mabuchi; Masakazu Yamagishi
Journal:  Eur J Clin Invest       Date:  2012-06-23       Impact factor: 4.686

Review 3.  Thematic review series: patient-oriented research. What we have learned about VLDL and LDL metabolism from human kinetics studies.

Authors:  Klaus G Parhofer; P Hugh R Barrett
Journal:  J Lipid Res       Date:  2006-05-23       Impact factor: 5.922

4.  Clinical utility gene card for: Familial hypobetalipoproteinaemia (APOB)--Update 2014.

Authors:  John R Burnett; Damon A Bell; Amanda J Hooper; Robert A Hegele
Journal:  Eur J Hum Genet       Date:  2014-10-22       Impact factor: 4.246

5.  Postprandial lipoprotein metabolism in familial hypobetalipoproteinemia.

Authors:  Amanda J Hooper; Ken Robertson; P Hugh R Barrett; Klaus G Parhofer; Frank M van Bockxmeer; John R Burnett
Journal:  J Clin Endocrinol Metab       Date:  2007-01-09       Impact factor: 5.958

6.  Diabetes mellitus in a new kindred with familial hypobetalipoproteinemia and an apolipoprotein B truncation (apoB-55).

Authors:  J I Pulai; M A Latour; P Y Kwok; G Schonfeld
Journal:  Atherosclerosis       Date:  1998-02       Impact factor: 5.162

Review 7.  Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management.

Authors:  Jooho Lee; Robert A Hegele
Journal:  J Inherit Metab Dis       Date:  2013-11-28       Impact factor: 4.982

Review 8.  A truncated species of apolipoprotein B (B-38.7) in a patient with homozygous hypobetalipoproteinemia associated with diabetes mellitus.

Authors:  K Ohashi; S Ishibashi; M Yamamoto; J Osuga; Y Yazaki; S Yukawa; N Yamada
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-08       Impact factor: 8.311

9.  Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia.

Authors:  Shoji Katsuda; Masa-Aki Kawashiri; Akihiro Inazu; Hayato Tada; Masayuki Tsuchida; Yoshibumi Kaneko; Tsuyoshi Nozue; Atsushi Nohara; Toshihide Okada; Junji Kobayashi; Ichiro Michishita; Hiroshi Mabuchi; Masakazu Yamagishi
Journal:  Clin Chim Acta       Date:  2008-09-24       Impact factor: 3.786

10.  Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels.

Authors:  K Nakajima; T Saito; A Tamura; M Suzuki; T Nakano; M Adachi; A Tanaka; N Tada; H Nakamura; E Campos
Journal:  Clin Chim Acta       Date:  1993-12-31       Impact factor: 3.786

View more
  3 in total

Review 1.  Low-Density Lipoprotein Cholesterol Level cannot be too Low: Considerations from Clinical Trials, Human Genetics, and Biology.

Authors:  Hayato Tada; Soichiro Usui; Kenji Sakata; Masayuki Takamura; Masa-Aki Kawashiri
Journal:  J Atheroscler Thromb       Date:  2020-04-30       Impact factor: 4.928

2.  A Healthy Family of Familial Hypobetalipoproteinemia Caused by a Protein-truncating Variant in the PCSK9 Gene.

Authors:  Hayato Tada; Hirofumi Okada; Akihiro Nomura; Atsushi Nohara; Masayuki Takamura; Masa-Aki Kawashiri
Journal:  Intern Med       Date:  2020-03-15       Impact factor: 1.271

Review 3.  Current Diagnosis and Management of Abetalipoproteinemia.

Authors:  Manabu Takahashi; Hiroaki Okazaki; Ken Ohashi; Masatsune Ogura; Shun Ishibashi; Sachiko Okazaki; Satoshi Hirayama; Mika Hori; Kota Matsuki; Shinji Yokoyama; Mariko Harada-Shiba
Journal:  J Atheroscler Thromb       Date:  2021-05-16       Impact factor: 4.928

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.